Axios was formed in 1997 by an entrepreneurial group of health experts who believed that patients deserved better. They shared a unique vision of an organization that would bring the distinct needs of the private and public sectors together to transform conventional access to healthcare models. And that’s exactly what we did.
At the peak of the HIV/AIDS pandemic, Axios founders designed and launched an unprecedented antiretroviral (ARV) access program at a time when access to quality medications in developing countries was unheard-of. Soon after, we launched the world’s first access programs for cancer medications.
Our early programs gave millions of patients access to critical, life-saving medications and opened the world’s eyes to the feasibility of alternative, more effective access models. 25 years later, Axios continues to break new ground in the design and implementation of access to healthcare solutions across Africa, Asia, Latin America, Middle East and Europe.
